Cargando…

COVID-19 in Solid Organ Transplantation: Disease Severity and Clinical Update

BACKGROUND: Solid organ transplant (SOT) recipients are a complex, immunocompromised population in whom greater coronavirus disease 2019 (COVID-19) mortality has been reported compared with the general population. METHODS: We examined a retrospective cohort of 58 SOT recipients with first-wave COVID...

Descripción completa

Detalles Bibliográficos
Autores principales: Arya, Akanksha, Li, Michael, Aburjania, Nana, Singh, Pooja, Royer, Tricia, Moss, Sean, Belden, Katherine A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7904466/
https://www.ncbi.nlm.nih.gov/pubmed/33757628
http://dx.doi.org/10.1016/j.transproceed.2021.02.014
_version_ 1783654935968088064
author Arya, Akanksha
Li, Michael
Aburjania, Nana
Singh, Pooja
Royer, Tricia
Moss, Sean
Belden, Katherine A.
author_facet Arya, Akanksha
Li, Michael
Aburjania, Nana
Singh, Pooja
Royer, Tricia
Moss, Sean
Belden, Katherine A.
author_sort Arya, Akanksha
collection PubMed
description BACKGROUND: Solid organ transplant (SOT) recipients are a complex, immunocompromised population in whom greater coronavirus disease 2019 (COVID-19) mortality has been reported compared with the general population. METHODS: We examined a retrospective cohort of 58 SOT recipients with first-wave COVID-19, comparing patients with severe and nonsevere illness. Additionally, SOT recipients are compared with general patients with first-wave COVID-19. RESULTS: Organs transplanted included 38 kidneys, 8 livers, 5 hearts, and 3 pancreases. Average SOT recipient age was 57.4 years; 62% were male; 46.6% were African American 36.2% were white. Comorbidities included hypertension (86%), chronic kidney disease (86%), diabetes mellitus (50%), coronary artery disease (26%), and chronic obstructive pulmonary disease (14%). Twenty patients had severe COVID-19 (34.5%) and 38 had nonsevere disease (65.5%). Severe disease was more common in older SOT recipients with comorbidities and was associated with cough, dyspnea, pneumonia, C-reactive protein >10 mg/L, and platelet count <150/μL. Sex, race, body mass index, time from transplant, baseline immunosuppression, and diagnosis month did not differ among those with severe and nonsevere COVID-19. Seventy percent of SOT recipients were hospitalized vs 27.2% of general patients with COVID-19 and inpatient SOT recipients had a higher mechanical ventilation rate. Though a trend toward longer length of stay, higher intensive care unit admission, and greater inpatient mortality was observed (19.5% vs 14.8%), these differences were not significant. CONCLUSIONS: The severe acute respiratory syndrome coronavirus 2 has greatly impacted SOT recipients. One-third of our SOT recipients seen during the first wave had severe illness with associated standard risk factors for poor outcome. Compared with general first-wave patients, more SOT recipients were hospitalized, although inpatient COVID-19 mortality did not significantly differ.
format Online
Article
Text
id pubmed-7904466
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Authors. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-79044662021-02-25 COVID-19 in Solid Organ Transplantation: Disease Severity and Clinical Update Arya, Akanksha Li, Michael Aburjania, Nana Singh, Pooja Royer, Tricia Moss, Sean Belden, Katherine A. Transplant Proc Article BACKGROUND: Solid organ transplant (SOT) recipients are a complex, immunocompromised population in whom greater coronavirus disease 2019 (COVID-19) mortality has been reported compared with the general population. METHODS: We examined a retrospective cohort of 58 SOT recipients with first-wave COVID-19, comparing patients with severe and nonsevere illness. Additionally, SOT recipients are compared with general patients with first-wave COVID-19. RESULTS: Organs transplanted included 38 kidneys, 8 livers, 5 hearts, and 3 pancreases. Average SOT recipient age was 57.4 years; 62% were male; 46.6% were African American 36.2% were white. Comorbidities included hypertension (86%), chronic kidney disease (86%), diabetes mellitus (50%), coronary artery disease (26%), and chronic obstructive pulmonary disease (14%). Twenty patients had severe COVID-19 (34.5%) and 38 had nonsevere disease (65.5%). Severe disease was more common in older SOT recipients with comorbidities and was associated with cough, dyspnea, pneumonia, C-reactive protein >10 mg/L, and platelet count <150/μL. Sex, race, body mass index, time from transplant, baseline immunosuppression, and diagnosis month did not differ among those with severe and nonsevere COVID-19. Seventy percent of SOT recipients were hospitalized vs 27.2% of general patients with COVID-19 and inpatient SOT recipients had a higher mechanical ventilation rate. Though a trend toward longer length of stay, higher intensive care unit admission, and greater inpatient mortality was observed (19.5% vs 14.8%), these differences were not significant. CONCLUSIONS: The severe acute respiratory syndrome coronavirus 2 has greatly impacted SOT recipients. One-third of our SOT recipients seen during the first wave had severe illness with associated standard risk factors for poor outcome. Compared with general first-wave patients, more SOT recipients were hospitalized, although inpatient COVID-19 mortality did not significantly differ. The Authors. Published by Elsevier Inc. 2021-05 2021-02-25 /pmc/articles/PMC7904466/ /pubmed/33757628 http://dx.doi.org/10.1016/j.transproceed.2021.02.014 Text en © 2021 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Arya, Akanksha
Li, Michael
Aburjania, Nana
Singh, Pooja
Royer, Tricia
Moss, Sean
Belden, Katherine A.
COVID-19 in Solid Organ Transplantation: Disease Severity and Clinical Update
title COVID-19 in Solid Organ Transplantation: Disease Severity and Clinical Update
title_full COVID-19 in Solid Organ Transplantation: Disease Severity and Clinical Update
title_fullStr COVID-19 in Solid Organ Transplantation: Disease Severity and Clinical Update
title_full_unstemmed COVID-19 in Solid Organ Transplantation: Disease Severity and Clinical Update
title_short COVID-19 in Solid Organ Transplantation: Disease Severity and Clinical Update
title_sort covid-19 in solid organ transplantation: disease severity and clinical update
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7904466/
https://www.ncbi.nlm.nih.gov/pubmed/33757628
http://dx.doi.org/10.1016/j.transproceed.2021.02.014
work_keys_str_mv AT aryaakanksha covid19insolidorgantransplantationdiseaseseverityandclinicalupdate
AT limichael covid19insolidorgantransplantationdiseaseseverityandclinicalupdate
AT aburjanianana covid19insolidorgantransplantationdiseaseseverityandclinicalupdate
AT singhpooja covid19insolidorgantransplantationdiseaseseverityandclinicalupdate
AT royertricia covid19insolidorgantransplantationdiseaseseverityandclinicalupdate
AT mosssean covid19insolidorgantransplantationdiseaseseverityandclinicalupdate
AT beldenkatherinea covid19insolidorgantransplantationdiseaseseverityandclinicalupdate